How advances in Exponential Technology are enabling entrepreneurs to do in Healthcare what was once only possible by government and large corporations.
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Exponential Technology in Health Care
1. Exponential Technology in Health Care
Joe Haslam
Associate Professor, IE Business School, Madrid.
Health Innovation Week
Trinity College Dublin, Ireland
15.40-16.00 on 22nd November
Paccar Theatre @ Science Gallery
2. All in Just 20 Minutes ...
1. Who Am I?
2. What is Exponential Technology?
3. Digital will solve some problems
4. But Exponential way more
5. Final Words
10. In 10 years, 64MB became 64GB
Information technology is it progresses exponentially . . . 30 steps linearly gets you to 30.
One, two, three, four, step 30 you’re at 30.
With exponential growth, it’s one, two, four, eight.
Step 30, you’re at a billion.”
18. The key is patient-driven research
biggest gains will come in the shape of better treatments for difficult
diseases. He sees patients increasingly getting together online and sharing
medical data and treatment histories.
19.
20. “The physician of the
future won´t show up
to work with a satchel
and a stethoscope,
but rather with a tablet
or smartphone that fits
neatly into the pocket
of her white coat”
28. Life is the f irst exponential technology.
Cells are computers – Andrew Hessel
29.
30.
31.
32. Alana Saarinen loves
playing golf and the
piano, listening to
music and hanging out
with friends.
In those respects,
she's like many
teenagers around the
world. Except she's
not, because every
cell in Alana's body
isn't like mine and
yours -
Alana is one of a few
people in the world
who have DNA from
three people
33.
34. Medicine’s new mantra is “the right drug for the right patient at the
right time.” In other words, medical treatments are gradually
shifting from a “one size fits all” approach to a more personalized
one, so that patients can be matched to the best therapy based
on their genetic makeup and other predictive factors. This
enables doctors to avoid prescribing a medication that is unlikely
to be effective or that might cause serious side effects in certain
patients.
Thus, although personalized medicine offers tremendous
potential for patients, regulators’ demands for vast clinical
studies to demonstrate the safety of new drugs, along with the
need to develop the diagnostic (biomarker) tests to accompany
the drug and also a clinical algorithm to guide the use of the
drug/diagnostic combination, could impose huge development
costs that might never be recovered by the manufacturers
35. “The biggest question in the long term is whether health insurers and
governments will keep paying up”
50. Joe Haslam
Lives in: Madrid, Spain
How to find me?
http://www.linkedin.com/in/joehas/
http://twitter.com/joehas/
http://joehas.tumblr.com/
https://snapchat.com/add/josehas/